
|Articles|January 15, 2005
FDA Approves Macugen
The FDA approved pegaptanib sodium injection (Macugen, Eyetech Pharmaceuticals and Pfizer Ophthalmics) for the treatment of neovascular age-related macular degeneration (AMD) on Dec. 17.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
2
FAQ: What clinicians need to know about OCU410 phase 2 ArMaDa results
3
EURETINA 2026: Real-world evidence on retinal biosimilars
4
EURETINA 2026: How a national registry is mapping inherited retinal disease in Portugal
5


















